Ted M. Dawson MD, PhD
Professor, Institute of Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MarylandTed Dawson, MD, PhD, is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases and Director of the Institute for Cell Engineering at the Johns Hopkins University School of Medicine. His laboratory focuses on neurodegenerative diseases. He pioneered the role of nitric oxide (NO) in neuronal injury in stroke, glutamate excitotoxicity and Parkinson’s disease (PD). He elucidated the molecular mechanisms by which NO kills neurons through the actions of poly (ADP-ribose) (PAR) polymerase and discovered a unique cell death pathway designated parthanatos, in which PAR functions as an intracellular signaling molecule that induces the release of apoptosis inducing factor (AIF) and activation of the nuclease activity of macrophage migration inhibitor factor (MIF). His laboratory has made important discoveries on how neurons die in genetic and sporadic models of PD. Dr. Dawson’s discoveries are enabling clinical strategies for disease modifying therapies for PD and other neurodegenerative diseases.
Disclosures
Dr. Dawson is a founder and inventor of technology of Neuraly, Inc., that has optioned from Johns Hopkins University, which is now a subsidiary of D & D Pharmatech; Dr. Dawson holds shares of stock options as well as equity in D & D Pharmatech.